You are currently viewing a new version of our website. To view the old version click .

Cardiac Amyloidosis and Heart Failure: Clinical Pathophysiology, Diagnosis, and Therapeutic Strategies

This special issue belongs to the section “Cardiology“.

Special Issue Information

Dear Colleagues,

Cardiac amyloidosis, once considered a rare and underdiagnosed cause of heart failure, is now recognized as an increasingly prevalent condition, particularly among elderly patients and those with heart failure with preserved ejection fraction. Advances in imaging, biomarkers, and non-invasive diagnostic techniques have significantly improved early recognition, while the therapeutic landscape has evolved rapidly with the introduction of disease-modifying agents. This Special Issue will provide a comprehensive overview of the clinical pathophysiological mechanisms linking amyloid deposition to cardiac dysfunction, highlight the latest developments in diagnostic tools—including cardiac imaging and novel biomarkers—and explore emerging and established therapeutic strategies. By bringing together original research, state-of-the-art reviews, and expert opinions, this Special Issue will enhance our understanding of the complex interplay between cardiac amyloidosis and heart failure.

We hope that this Special Issue will serve as a valuable resource for clinicians, researchers, and all professionals engaged in the care and study of patients with cardiac amyloidosis.

Dr. Ilaria Dentamaro
Dr. Laura Fusini
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cardiology
  • cardiac heart failure
  • cardiac amyloidosis
  • cardiac imaging
  • cardiomyopathy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
J. Clin. Med. - ISSN 2077-0383